Ali Janabi-Al
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Real-world diagnostic performance of artificial intelligence in skin cancer screening.
Journal: Skin health and disease
Published: April 20, 2026
Blood Single-Cell Transcriptomic and Proteomic Signatures of Paradoxical Eczema in Patients with Psoriasis Treated with Biologics.
Journal: The Journal of investigative dermatology
Published: July 08, 2024
Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis.
Journal: JAMA dermatology
Published: December 06, 2023
Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics.
Journal: The Journal of allergy and clinical immunology
Published: February 20, 2023
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with Biologics.
Journal: The Journal of investigative dermatology
Published: November 08, 2022
The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study.
Journal: The British journal of dermatology
Published: August 03, 2022
Global Guidelines in Dermatology Mapping Project (GUIDEMAP): a systematic review of alopecia areata clinical practice guidelines.
Journal: Clinical and experimental dermatology
Published: June 26, 2022
Paradoxical eczema in patients with psoriasis receiving biologics: a case series.
Journal: Clinical and experimental dermatology
Published: October 24, 2021
Bimekizumab: a dual IL-17A and IL-17F inhibitor for the treatment of psoriasis and psoriatic arthritis.
Journal: Expert review of clinical immunology
Published: August 13, 2021
Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre.
Journal: Dermatology and therapy
Published: October 05, 2020
Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports.
Journal: Clinical case reports
Published: November 19, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026